Moreover, TLR2 expression is upregulated in peripheral blood mononuclear cells (PBMCs) from MS patients, with PBMCs from RRMS (relapsing-remitting MS) being hypersensitive to TLR4 activation (152). The gene discussed is TLR4; the disease is myeloid sarcoma.